Mesoporous silica-coated bismuth nanohybrids as a new platform for photoacoustic/computed tomography imaging and synergistic chemophotothermal therapy

Papers of special note have been highlighted as: • of interest; ••of considerable interest

References

• 1 Donaldson KL, Goolsby GL, Wahl AF. Cytotoxicity of the anticancer agents cisplatin and taxol during cell proliferation and the cell cycle. Int. J. Cancer 57(6), 847–855 (1994).
  Medline CASGoogle Scholar
• 2 Kouranos V, Dimopoulos G, Vassias A, Syrigos AN. Chemotherapy-induced neutropenia in lung cancer patients: the role of antibiotic prophylaxis. Cancer Lett. 313(1), 9–14 (2011).
  Medline CASGoogle Scholar
• 3 Kintzel PE, Dorr RT. Anticancer drug renal toxicity and elimination: dosing guidelines for altered renal function. Cancer Treat. Rev. 21(1), 33–64 (1995).
  Medline CASGoogle Scholar
• 4 Szakács G, Paterson JK, Ludwig JA, Booth-Genthe C, Gottesman MM. Targeting multidrug resistance in cancer. Nat. Rev. Drug Discov. 5(3), 219–234 (2006).
  Medline CASGoogle Scholar
• 5 Torchilin VP. Recent advances with liposomes as pharmaceutical carriers. Nat. Rev. Drug Discov. 4(2), 145–160 (2005).
  Medline CASGoogle Scholar
• 6 Jing L, Liang X, Li X, Yang Y, Dai Z. Covalent attachment of Mn-porphyrin onto doxorubicin-loaded poly(lactic acid) nanoparticles for potential magnetic resonance imaging and pH-sensitive drug delivery. Acta Biomater. 9(12), 9434–9441 (2013).
  Medline CASGoogle Scholar
• 7 Song G, Wang Q, Wang Y et al. Nanocomposites: a low-toxic multifunctional nanoplatform based on Cu₉S₅@mSiO₂ core-shell nanocomposites: combining photothermal- and chemotherapies with infrared thermal imaging for cancer treatment. Adv. Funct. Mater. 23(35), 4281–4292 (2013). • Illustrates a successful example of mSiO2 based nanoparticles for chemophotothermal synergistic therapy.
  CASGoogle Scholar
• 8 Tang J, Kong B, Wu H et al. Carbon nanodots featuring efficient FRET for real-time monitoring of drug delivery and two-photon imaging. Adv. Mater. 25(45), 6569–6574 (2013).
  Medline CASGoogle Scholar
• 9 Zheng T, Li GG, Zhou F, Wu R, Zhu JJ, Wang H. Gold-nanosponge-based multistimuli-responsive drug vehicles for targeted chemo-photothermal therapy. Adv. Mater. 28(37), 8218–8226 (2016).
  Medline CASGoogle Scholar
• 10 Song N, Yang YW. Molecular and supramolecular switches on mesoporous silica nanoparticles. Chem. Soc. Rev. 44(11), 3474–3504 (2015). • Summarizes recent advances related to the therapeutic use of mesoporous silica nanoparticles.
  Medline CASGoogle Scholar
• 11 Wu M, Wang X, Yang Y. Polymer Nanoassembly as delivery systems and anti-bacterial toolbox: from PGMAs to MSN@PGMAs. Chem. Rec. 18(1), 45–54 (2018).
  Medline CASGoogle Scholar
• 12 Yang Y, Sun Y, Song N. Switchable host–guest systems on surfaces. Acc. Chem. Res. 47(7), 1950–1960 (2014).
  Medline CASGoogle Scholar
• 13 Li Z, Yang YW. Creation and bioapplications of porous organic polymer materials. J. Mater. Chem. B 5(47), 9278–9290 (2017).
  Medline CASGoogle Scholar
• 14 Fang J, Nakamura H, Maeda H. The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv. Drug Deliver. Rev. 63(3), 136–151 (2011).
  Medline CASGoogle Scholar
• 15 He Q, Shi J. MSN anti-cancer nanomedicines: chemotherapy enhancement, overcoming of drug resistance, and metastasis inhibition. Adv. Mater. 26(3), 391–411 (2014).
  Medline CASGoogle Scholar
• 16 Yang P, Gai S, Lin J. Functionalized mesoporous silica materials for controlled drug delivery. Chem. Soc. Rev. 41(9), 3679–3698 (2012). •• Demonstrates how to synthesize functionalized mesoporous silica nanoparticles.
  Medline CASGoogle Scholar
• 17 Zhu YF, Shi JL, Li YS, Chen HR, Shen WH, Dong XP. Storage and release of ibuprofen drug molecules in hollow mesoporous silica spheres with modified pore surface. Micropor. Mesopor. Mat. 85(1), 75–81 (2005).
  CASGoogle Scholar
• 18 Yang J, Zhang F, Chen Y et al. Core-shell Ag@SiO₂@mSiO₂ mesoporous nanocarriers for metal-enhanced fluorescence. Chem. Commun. 47(42), 11618–11620 (2011).
  Medline CASGoogle Scholar
• 19 Li QL, Sun Y, Sun YL et al. Mesoporous silica nanoparticles coated by layer-by-layer self-assembly using cucurbit [7]uril for in vitro and in vivo anticancer drug release. Chem. Mater. 26(22), 6418–6431 (2014).
  Medline CASGoogle Scholar
• 20 Li Z, Barnes JC, Bosoy A, Stoddart JF, Zink JI. Mesoporous silica nanoparticles in biomedical applications. Chem. Soc. Rev. 41(7), 2590–2605 (2012).
  Medline CASGoogle Scholar
• 21 Yang Y. Towards biocompatible nanovalves based on mesoporous silica nanoparticles. Med. Chem. Commun. 2(11), 1033–1049 (2011).
  CASGoogle Scholar
• 22 Zhou H, Wang X, Tang J, Yang Y. Tuning the growth, crosslinking, and gating effect of disulfide-containing PGMAs on the surfaces of mesoporous silica nanoparticles for redox/pH dual-controlled cargo release. Polym. Chem. 7(12), 2171–2179 (2016).
  CASGoogle Scholar
• 23 Li Q, Xu S, Zhou H et al. pH and glutathione dual-responsive dynamic cross-linked supramolecular network on mesoporous silica nanoparticles for controlled anticancer drug-release. ACS Appl. Mater. Interfaces 7(51), 28656–28664 (2015).
  Medline CASGoogle Scholar
• 24 Li H, Tan L, Jia P et al. Near-infrared light-responsive supramolecular nanovalve based on mesoporous silica–coated gold nanorods. Chem. Sci. 5(7), 2804–2808 (2014).
  CASGoogle Scholar
• 25 Song G, Chao Y, Chen Y et al. All-in-one theranostic nanoplatform based on hollow TaOx for chelator-free labeling imaging, drug delivery, and synergistically enhanced radiotherapy. Adv. Funct. Mater. 26(45), 8243–8254 (2016).
  CASGoogle Scholar
• 26 Li Z, Liu J, Hu Y et al. Multimodal imaging-guided antitumor photothermal therapy and drug delivery using bismuth selenide spherical-sponge. ACS Nano 10(10), 9646–9658 (2016). •• Illustrates a successful example of Bi nanoparticles for chemophotothermal synergistic therapy.
  Medline CASGoogle Scholar
• 27 Li Z, Hu Y, Jiang T et al. Human-serum-albumin-coated prussian blue nanoparticles as pH-/thermotriggered drug-delivery vehicles for cancer thermochemotherapy. Part. Part. Syst. Char. 33(1), 53–62 (2016).
  Google Scholar
• 28 Xu Q, Leong J, Chua QY et al. Combined modality doxorubicin-based chemotherapy and chitosan-mediated p53 gene therapy using double-walled microspheres for treatment of human hepatocellular carcinoma. Biomaterials 34(21), 5149–5162 (2013).
  Medline CASGoogle Scholar
• 29 Ping H, Qian X, Yu C et al. Metalloporphyrin-encapsulated biodegradable nanosystems for highly efficient magnetic resonance imaging-guided sonodynamic cancer therapy. J. Am. Chem. Soc. 139(3), 1275–1284 (2017).
  MedlineGoogle Scholar
• 30 Yao X, Niu X, Ma K et al. Graphene quantum dots-capped magnetic mesoporous silica nanoparticles as a multifunctional platform for controlled drug delivery, magnetic hyperthermia, and photothermal therapy. Small 13(2), 1602225 (2017).
  Google Scholar
• 31 Tian Z, Yao X, Ma K et al. Metal–organic framework/graphene quantum dot nanoparticles used for synergistic chemo- and photothermal therapy. ACS Omega 2(3), 1249–1258 (2017).
  Medline CASGoogle Scholar
• 32 Yao X, Tian Z, Liu J, Zhu Y, Hanagata N. Mesoporous silica nanoparticles capped with graphene quantum dots for potential chemo–photothermal synergistic cancer therapy. Langmuir 33(2), 591–599 (2017).
  Medline CASGoogle Scholar
• 33 Tao C, Zhu Y. Magnetic mesoporous silica nanoparticles for potential delivery of chemotherapeutic drugs and hyperthermia. Dalton T. 43(41), 15482–15490 (2014).
  Medline CASGoogle Scholar
• 34 Tian Z, Yu X, Ruan Z, Zhu M, Zhu Y, Hanagata N. Magnetic mesoporous silica nanoparticles coated with thermo-responsive copolymer for potential chemo- and magnetic hyperthermia therapy. Micropor. Mesopor. Mater. 256, 1–9 (2018).
  CASGoogle Scholar
• 35 Liu T, Wang C, Gu X et al. Drug delivery with PEGylated MoS₂ nano-sheets for combined photothermal and chemotherapy of cancer. Adv. Mater. 26(21), 3433–3440 (2014).
  MedlineGoogle Scholar
• 36 Li Z, Hu Y, Howard KA et al. Multifunctional bismuth selenide nanocomposites for antitumor thermo-chemotherapy and imaging. ACS Nano 10(1), 984–997 (2016).
  Medline CASGoogle Scholar
• 37 Li Z, Hu Y, Chang M et al. Highly porous PEGylated Bi₂S₃ nano-urchins as a versatile platform for in vivo triple-modal imaging, photothermal therapy and drug delivery. Nanoscale 8(35), 16005–16016 (2016). •• Illustrates a successful example of porous PEGylated Bi2S3 nanourchins for in vivo triple-modal imaging, photothermal therapy and drug delivery.
  Medline CASGoogle Scholar
• 38 Liang X, Li Y, Li X et al. PEGylated polypyrrole nanoparticles conjugating gadolinium chelates for dual-modal MRI/photoacoustic imaging guided photothermal therapy of cancer. Adv. Funct. Mater. 25(9), 1451–1462 (2015).
  CASGoogle Scholar
• 39 Yi X, Yang K, Liang C et al. Imaging-guided combined photothermal and radiotherapy to treat subcutaneous and metastatic tumors using Iodine-131-doped copper sulfide nanoparticles. Adv. Funct. Mater. 25(29), 4689–4699 (2015).
  CASGoogle Scholar
• 40 Song G, Liang C, Gong H et al. Core–shell MnSe@Bi₂Se₃ fabricated via a cation exchange method as novel nanotheranostics for multimodal imaging and synergistic thermoradiotherapy. Adv. Mater. 27(40), 6110–6117 (2015). • Illustrates a successful example of core–shell Bi based nanoparticles for multimodal imaging and synergistic thermoradiotherapy.
  Medline CASGoogle Scholar
• 41 Zhang Z, Wang L, Wang J et al. Mesoporous silica–coated gold nanorods as a light-mediated multifunctional theranostic platform for cancer treatment. Adv. Mater. 24(11), 1418–1423 (2012).
  Medline CASGoogle Scholar
• 42 Cheng L, Liu J, Gu X et al. PEGylated WS₂ nanosheets as a multifunctional theranostic agent for in vivo dual-modal CT/photoacoustic imaging guided photothermal therapy. Adv. Mater. 26(12), 1886–1893 (2014).
  Medline CASGoogle Scholar
• 43 Li Z, Zeng Y, Zhang D et al. Glypican-3 antibody functionalized Prussian blue nanoparticles for targeted MR imaging and photothermal therapy of hepatocellular carcinoma. J. Mater. Chem. B 2(23), 3686–3696 (2014).
  Medline CASGoogle Scholar
• 44 Yang K, Zhang S, Zhang G, Sun X, Lee ST, Liu Z. Graphene in mice: ultrahigh in vivo tumor uptake and efficient photothermal therapy. Nano Lett. 10(9), 3318–3323 (2010).
  Medline CASGoogle Scholar
• 45 Yang T, Wang Y, Ke H et al. Protein-nanoreactor-assisted synthesis of semiconductor nanocrystals for efficient cancer theranostics. Adv. Mater. 28(28), 5923–5930 (2016).
  Medline CASGoogle Scholar
• 46 Xie J, Lee JY, Wang DI. Seedless, surfactantless, high-yield synthesis of branched gold nanocrystals in HEPES buffer solution. Chem. Mater. 19(11), 2823–2830 (2007).
  CASGoogle Scholar
• 47 Zhang C, Fu YY, Zhang X, Yu C, Zhao Y, Sun SK. BSA-directed synthesis of CuS nanoparticles as a biocompatible photothermal agent for tumor ablation in vivo. Dalton T. 44(29), 13112–13118 (2015).
  Medline CASGoogle Scholar
• 48 Li Z, Liu J, Hu Y et al. Biocompatible PEGylated bismuth nanocrystals: 'all-in-one' theranostic agent with triple-modal imaging and efficient in vivo photothermal ablation of tumors. Biomaterials 141, 284–295 (2017).
  Medline CASGoogle Scholar
• 49 You J, Zhang G, Li C. Exceptionally high payload of doxorubicin in hollow gold nanospheres for near-infrared light-triggered drug-release. ACS Nano 4(2), 1033–1041 (2010).
  Medline CASGoogle Scholar
• 50 Ito A, Shinkai M, Honda H et al. Heat shock protein 70 expression induces antitumor immunity during intracellular hyperthermia using magnetite nanoparticles. Cancer Immunol. Immun. 52(2), 80–88 (2003).
  Medline CASGoogle Scholar
• 51 Brown AL, Naha PC, Benavides-Montes V, Litt HI. Synthesis, x-ray opacity, and biological compatibility of ultra-high payload elemental bismuth nanoparticle x-ray contrast agents. Chem. Mater. 26(7), 2266–2274 (2014).
  Medline CASGoogle Scholar
• 52 Sherlock SP, Tabakman SM, Xie L, Dai H. Photothermally enhanced drug delivery by ultra-small multifunctional FeCo/graphitic-shell nanocrystals. ACS Nano 5(2), 1505–1512 (2011).
  Medline CASGoogle Scholar
• 53 Roper DK, Ahn W, Hoepfner M. Microscale heat transfer transduced by surface plasmon resonant gold nanoparticles. J. Phys. Chem. C. 111(9), 3636–3641 (2007).
  CASGoogle Scholar
• 54 Hessel CM, Pattani VP, Rasch M et al. Copper selenide nanocrystals for photothermal therapy. Nano Lett. 11(6), 2560–2566 (2011).
  Medline CASGoogle Scholar
• 55 Wang C, Xu H, Liang C et al. Iron oxide@polypyrrole nanoparticles as a multifunctional drug carrier for remotely controlled cancer therapy with synergistic antitumor effect. ACS Nano 7(8), 6782–6795 (2013).
  Medline CASGoogle Scholar
• 56 Shen P, Hawksworth J, Lovato J et al. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy with mitomycin C for peritoneal carcinomatosis from nonappendiceal colorectal carcinoma. Ann. Surg. Oncol. 11(2), 178–186 (2004).
  MedlineGoogle Scholar
• 57 Li J, Jiang F, Yang B et al. Topological insulator bismuth selenide as a theranostic platform for simultaneous cancer imaging and therapy. Sci. Rep. 3(6), 1998 (2013).
  MedlineGoogle Scholar
• 58 Liu J, Zheng X, Yan L et al. Bismuth sulfide nanorods as a precision nanomedicine for in vivo photothermal therapy of tumor. ACS Nano 9(1), 696–707 (2015).
  Medline CASGoogle Scholar
• 59 Kim D, Park S, Lee JH, Jeong YY, Jon S. Antibiofouling polymer-coated gold nanoparticles as a contrast agent for in vivo x-ray computed tomography imaging. J. Am. Chem. Soc. 129(24), 7661–7665 (2007).
  Medline CASGoogle Scholar
• 60 Ke H, Yue X, Wang J et al. Gold nanoshelled liquid perfluorocarbon nanocapsules for combined dual modal ultrasound/CT imaging and photothermal therapy of cancer. Small 10(6), 1220–1227 (2014).
  Medline CASGoogle Scholar